Gone are the days when gadgets that monitor one’s vital statistics were a figment of the rich imagination of science fiction writers and movie directors. Today, digital health gadgets have become an essential part of our life. A new survey that was conducted among pharmaceutical and life science industry experts found out that digital health monitoring gadgets will play an important role in health care. This survey was conducted by a Durham-based mobile healthcare startup, Validic. A huge number of those were surveyed reported that digital data is going to increase exponentially in the next five years.
Digital data is going to play a vital role in several spheres like finding new drugs and to help keep the costs of drugs down. A huge number of executives who took part in the survey reported that digital data is already being collected in around sixty percent of the clinical trials being done. Drew Schiller, the Founder and chief executive officer of Validic, in an interview, said that digital health technologies and health related data obtained from patients is essential to increase the efficiency of operations and to center the pharmaceutical industry on patients. A major benefit of this remotely collected data is that it is highly accurate and reduced errors significantly. Also, this method ensures the lowering of the burden on patients.
Some of the key discoveries of the survey are:
· The face of Digital health is highly changing and is undergoing a huge transition.
· It is highly imperative that drug development costs are cut down to benefit patients.
· Digital health is highly beneficial in the management of chronic diseases.
· Technical difficulties and challenges associated with the collection of data have been addressed by both pharmaceutical companies as well as technology providers.
So if you still haven’t exploited the potential of a digital health tracking gadget, then it is about time you get started.
Read also – World’s Largest Telescope To Aid In The Search For Alien Life
The very nature of innovation has undergone a drastic change over the past decade. One of the major factors behind this change is the way which we handle huge volumes of data. Digital data collection and analysis has transformed industries across all verticals. In Research dependent industries like Pharmaceutical and Biotech, the reliability on data has always been vital. However, until very recently, the huge potential of data had not been explored. However, All that’s changing with the help of cloud software.
What exactly is the Cloud?
Unlike conventional software, cloud software is not installed on local systems. It is rather deployed on a common server and is used by several organizations collectively. This offers manifold benefits. With the cloud, the time for installing and updating new software is within minutes rather than taking weeks like with conventional software. The best benefit of cloud software is reduced operational cost. Instead of shelling out thousands of dollars to buy software, you can use it for a fraction of the cost. Also, updates and newer improvements can be made on the run, benefitting the end users immensely.
How Cloud Software Helps in the Life Sciences?
Just like all industries benefit from Cloud based software, life sciences too can benefit tremendously from it. Seamless collaboration, automation of experiments, highly advanced analytics and higher operational efficiency is a few of the main benefits of cloud software in the life sciences.
The Future is in the Cloud
Speed matters a lot when it comes to life sciences. Cloud based software ensures that the time to complete experiments is kept to a minimum. This is highly imperative to gain the edge over competitors. Cloud based software also offers the potential to explore artificial intelligence and machine aided learning. So, life sciences firms are gearing up to take their experiments to the cloud.
A new life science company all set to open shop in the Seaport District of Boston aims to make animal testing obsolete. They eventually want to see that drug manufacturers put an end to testing their drugs on mice and other animals. Currently all the leading drug manufacturers insert samples of the drug into mice to test the effects of their drugs on the different organs of these tiny creatures.
The company plans to do away with animal testing by making use of plastic chips to mimic the role of drugs in the body. The benefits of such a mission are manifold. Apart from taking a more humanitarian approach to drug testing, it is highly efficient. Using a system of two-inch long plastic chips is highly easier that using a lab full of live animals. Emulate, Inc is currently headed in this direction. It is to be noted that this start-up is a spin off from the Wyss Institute of Harvard.
Emulate Inc, opened its headquarters earlier this week at Drydock Avenue in the Innovation District of Boston. This is the area that was recently in the news, when GE announced its plans to build its new Global headquarters later this year. The 20,000 square foot space can accommodate not only its current employees but also has provisions for future employees too.
Geraldine Hamilton, the Chief Science Officer of Emulate Inc stated that the company has already created a series of plastic chips that mimic the role of the major organs in the human body. These plastic chips contain living cells attached to them. They are highly flexible and mimic the role of organs as close to reality as possible. The basic idea behind these cells is that sample drugs can be inserted into the channels and monitored to see how they impact the organs, which the chips mimic.